HomeCompareINDFF vs MRK

INDFF vs MRK: Dividend Comparison 2026

INDFF yields 2.58% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $34.2K in total portfolio value
10 years
INDFF
INDFF
● Live price
2.58%
Share price
$0.31
Annual div
$0.01
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.5K
Annual income
$304.83
Full INDFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — INDFF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodINDFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, INDFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
INDFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INDFF
Annual income on $10K today (after 15% tax)
$219.35/yr
After 10yr DRIP, annual income (after tax)
$259.11/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,337.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INDFF + MRK for your $10,000?

INDFF: 50%MRK: 50%
100% MRK50/50100% INDFF
Portfolio after 10yr
$40.6K
Annual income
$5,209.30/yr
Blended yield
12.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

INDFF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INDFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricINDFFMRK
Forward yield2.58%2.81%
Annual dividend / share$0.01$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$23.5K$57.7K
Annual income after 10y$304.83$10,113.78
Total dividends collected$2.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: INDFF vs MRK ($10,000, DRIP)

YearINDFF PortfolioINDFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,958$258.06$11,213$373.04$255.00MRK
2$11,989$264.29$12,667$512.06$678.00MRK
3$13,099$270.25$14,439$708.14$1.3KMRK
4$14,292$275.94$16,640$988.16$2.3KMRK
5$15,574$281.37$19,432$1,394.07$3.9KMRK
6$16,950$286.55$23,057$1,992.90$6.1KMRK
7$18,428$291.48$27,889$2,894.79$9.5KMRK
8$20,014$296.16$34,518$4,286.29$14.5KMRK
9$21,716$300.61$43,912$6,494.35$22.2KMRK
10$23,541$304.83$57,714$10,113.78$34.2KMRK

INDFF vs MRK: Complete Analysis 2026

INDFFStock

Indofood Agri Resources Ltd., together with its subsidiaries, operates as a vertically integrated agribusiness company in Singapore, Indonesia, China, Nigeria, Timor Leste, Germany, the Philippines, Myanmar, and internationally. It engages in the research and development; oil palm seed breeding; oil palm cultivation and milling; crude palm oil production and refining; rubber, sugar cane, cocoa, and tea cultivation; and industrial timber plantation activities. The company operates in two segments, Plantations, and Edible Oils and Fats. The Plantations segment is involved in the development and maintenance of oil palm, rubber, and sugar cane plantations; and other business activities relating to processing, marketing, and selling palm oil, rubber, and sugar cane. The Edible Oils and Fats segment produces, markets, and sells edible oil, margarine, shortening, and other related products, as well as its derivative products. It offers cooking oil under the Bimoli, Bimoli Spesial, Delima, Amanda, and Happy brands; and margarine and shortening products under the Amanda, Palmia, Royal Palmia, Simas, Malinda, and Delima brands. As of December 31, 2021, the company had a planted area of approximately 300,749 hectares, including 250,615 hectares of oil palm; 16,228 hectares of rubber; 14,411 hectares of sugar cane; and 19,495 hectares of other crops. It also owns and operates bulking facilities; provides transportation, investment, management, and technical services; and operates in the macronutrients mix fertilizers and prefabrication industries. The company was incorporated in 2001 and is headquartered in Singapore. Indofood Agri Resources Ltd. is a subsidiary of Indofood Singapore Holdings Pte. Ltd.

Full INDFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this INDFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INDFF vs SCHDINDFF vs JEPIINDFF vs OINDFF vs KOINDFF vs MAININDFF vs JNJINDFF vs ABBVINDFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.